Literature DB >> 23754276

UV-triggered affinity capture identifies interactions between the Plasmodium falciparum multidrug resistance protein 1 (PfMDR1) and antimalarial agents in live parasitized cells.

Ralf Brunner1, Caroline L Ng, Hamed Aissaoui, Myles H Akabas, Christoph Boss, Reto Brun, Paul S Callaghan, Olivier Corminboeuf, David A Fidock, Ithiel J Frame, Bibia Heidmann, Amélie Le Bihan, Paul Jenö, Corinna Mattheis, Suzette Moes, Ingrid B Müller, Michelle Paguio, Paul D Roepe, Romain Siegrist, Till Voss, Richard W D Welford, Sergio Wittlin, Christoph Binkert.   

Abstract

A representative of a new class of potent antimalarials with an unknown mode of action was recently described. To identify the molecular target of this class of antimalarials, we employed a photo-reactive affinity capture method to find parasite proteins specifically interacting with the capture compound in living parasitized cells. The capture reagent retained the antimalarial properties of the parent molecule (ACT-213615) and accumulated within parasites. We identified several proteins interacting with the capture compound and established a functional interaction between ACT-213615 and PfMDR1. We surmise that PfMDR1 may play a role in the antimalarial activity of the piperazine-containing compound ACT-213615.

Entities:  

Keywords:  ACT-213615; Affinity Capture; Drug Action; Mode of Action; Multidrug Transporters; PfMDR1; Photoaffinity Labeling; Plasmodium; Protein Drug Interactions

Mesh:

Substances:

Year:  2013        PMID: 23754276      PMCID: PMC3829344          DOI: 10.1074/jbc.M113.453159

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Delaying antimalarial drug resistance with combination chemotherapy.

Authors:  N J White
Journal:  Parassitologia       Date:  1999-09

2.  Capture compound mass spectrometry: a technology for the investigation of small molecule protein interactions.

Authors:  Hubert Köster; Daniel P Little; Peng Luan; Rolf Muller; Suhaib M Siddiqi; Subramanian Marappan; Ping Yip
Journal:  Assay Drug Dev Technol       Date:  2007-06       Impact factor: 1.738

Review 3.  A role for membrane potential in regulating GPCRs?

Authors:  Martyn P Mahaut-Smith; Juan Martinez-Pinna; Iman S Gurung
Journal:  Trends Pharmacol Sci       Date:  2008-07-11       Impact factor: 14.819

Review 4.  Purine salvage pathways in the intraerythrocytic malaria parasite Plasmodium falciparum.

Authors:  Megan J Downie; Kiaran Kirk; Choukri Ben Mamoun
Journal:  Eukaryot Cell       Date:  2008-06-20

5.  Calf liver nuclear N-acetyltransferases. Purification and properties of two enzymes with both spermidine acetyltransferase and histone acetyltransferase activities.

Authors:  P R Libby
Journal:  J Biol Chem       Date:  1978-01-10       Impact factor: 5.157

6.  Spiroindolones, a potent compound class for the treatment of malaria.

Authors:  Matthias Rottmann; Case McNamara; Bryan K S Yeung; Marcus C S Lee; Bin Zou; Bruce Russell; Patrick Seitz; David M Plouffe; Neekesh V Dharia; Jocelyn Tan; Steven B Cohen; Kathryn R Spencer; Gonzalo E González-Páez; Suresh B Lakshminarayana; Anne Goh; Rossarin Suwanarusk; Timothy Jegla; Esther K Schmitt; Hans-Peter Beck; Reto Brun; Francois Nosten; Laurent Renia; Veronique Dartois; Thomas H Keller; David A Fidock; Elizabeth A Winzeler; Thierry T Diagana
Journal:  Science       Date:  2010-09-03       Impact factor: 47.728

7.  Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential.

Authors:  Jose M Coteron; María Marco; Jorge Esquivias; Xiaoyi Deng; Karen L White; John White; Maria Koltun; Farah El Mazouni; Sreekanth Kokkonda; Kasiram Katneni; Ravi Bhamidipati; David M Shackleford; Iñigo Angulo-Barturen; Santiago B Ferrer; María Belén Jiménez-Díaz; Francisco-Javier Gamo; Elizabeth J Goldsmith; William N Charman; Ian Bathurst; David Floyd; David Matthews; Jeremy N Burrows; Pradipsinh K Rathod; Susan A Charman; Margaret A Phillips
Journal:  J Med Chem       Date:  2011-07-14       Impact factor: 7.446

8.  In vitro assessment of the pharmacodynamic properties of DB75, piperaquine, OZ277 and OZ401 in cultures of Plasmodium falciparum.

Authors:  Sandra Hofer; Reto Brun; Sonja Maerki; Hugues Matile; Christian Scheurer; Sergio Wittlin
Journal:  J Antimicrob Chemother       Date:  2008-07-30       Impact factor: 5.790

9.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

10.  PfMDR1: mechanisms of transport modulation by functional polymorphisms.

Authors:  Pedro Eduardo Ferreira; Gabrielle Holmgren; Maria Isabel Veiga; Per Uhlén; Akira Kaneko; José Pedro Gil
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

View more
  7 in total

1.  Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.

Authors:  Manu Vanaerschot; Leonardo Lucantoni; Tao Li; Jill M Combrinck; Andrea Ruecker; T R Santha Kumar; Kelly Rubiano; Pedro E Ferreira; Giulia Siciliano; Sonia Gulati; Philipp P Henrich; Caroline L Ng; James M Murithi; Victoria C Corey; Sandra Duffy; Ori J Lieberman; M Isabel Veiga; Robert E Sinden; Pietro Alano; Michael J Delves; Kim Lee Sim; Elizabeth A Winzeler; Timothy J Egan; Stephen L Hoffman; Vicky M Avery; David A Fidock
Journal:  Nat Microbiol       Date:  2017-08-14       Impact factor: 17.745

Review 2.  Recent updates in the discovery and development of novel antimalarial drug candidates.

Authors:  John Okombo; Kelly Chibale
Journal:  Medchemcomm       Date:  2018-02-02       Impact factor: 3.597

Review 3.  New insight-guided approaches to detect, cure, prevent and eliminate malaria.

Authors:  Sushil Kumar; Renu Kumari; Richa Pandey
Journal:  Protoplasma       Date:  2014-10-17       Impact factor: 3.356

4.  CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs.

Authors:  Caroline L Ng; Giulia Siciliano; Marcus C S Lee; Mariana J de Almeida; Victoria C Corey; Selina E Bopp; Lucia Bertuccini; Sergio Wittlin; Rachel G Kasdin; Amélie Le Bihan; Martine Clozel; Elizabeth A Winzeler; Pietro Alano; David A Fidock
Journal:  Mol Microbiol       Date:  2016-05-07       Impact factor: 3.501

5.  Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.

Authors:  Amélie Le Bihan; Ruben de Kanter; Iñigo Angulo-Barturen; Christoph Binkert; Christoph Boss; Reto Brun; Ralf Brunner; Stephan Buchmann; Jeremy Burrows; Koen J Dechering; Michael Delves; Sonja Ewerling; Santiago Ferrer; Christoph Fischli; Francisco Javier Gamo-Benito; Nina F Gnädig; Bibia Heidmann; María Belén Jiménez-Díaz; Didier Leroy; Maria Santos Martínez; Solange Meyer; Joerg J Moehrle; Caroline L Ng; Rintis Noviyanti; Andrea Ruecker; Laura María Sanz; Robert W Sauerwein; Christian Scheurer; Sarah Schleiferboeck; Robert Sinden; Christopher Snyder; Judith Straimer; Grennady Wirjanata; Jutta Marfurt; Ric N Price; Thomas Weller; Walter Fischli; David A Fidock; Martine Clozel; Sergio Wittlin
Journal:  PLoS Med       Date:  2016-10-04       Impact factor: 11.069

Review 6.  Targeting Channels and Transporters in Protozoan Parasite Infections.

Authors:  Anna Meier; Holger Erler; Eric Beitz
Journal:  Front Chem       Date:  2018-03-27       Impact factor: 5.221

Review 7.  Chemical Biology Tools To Investigate Malaria Parasites.

Authors:  Johannes Broichhagen; Nicole Kilian
Journal:  Chembiochem       Date:  2021-03-31       Impact factor: 3.164

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.